BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...

August 07, 2024 | News

FDA Grants Rare Pediatric Disease Designation to META Pharmaceuticals' Investigational Drug META-001-PH

META Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its investiga...

August 06, 2024 | News

Biosyngen and A*STAR Forge Strategic Alliance to Advance Autoimmune Therapies

Biosyngen has announced a strategic collaboration with Singapore's Agency for Science, Technology and Research (A*STAR) to enhance autoimmune the...

August 02, 2024 | News

Innovent Biologics and Sanegene Bio USA Dose First Participant in Phase 1 Trial of Promising siRNA Hypertension Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

August 02, 2024 | News

JelloX Biotech Collaborates with Mayo Clinic to Enhance 3D Digital Imaging and AI Analysis for Precision Cancer Diagnosis

JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to f...

August 01, 2024 | News

Thermo Fisher Scientific Launches Innovative Pre-Transplant Assay to Enhance Kidney Transplant Outcomes

Thermo Fisher Scientific, the world leader in serving science, has introduced a new pre-transplant risk assessment assay via its CLIA laboratory in Fishers...

July 31, 2024 | News

Menarini Group Announces Positive Phase 3 Trial Results for Obicetrapib in Lowering LDL-C

-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically ...

July 30, 2024 | News

Pierre Fabre Laboratories Receives Positive CHMP Opinion for BRAFTOVI® + MEKTOVI® in Advanced NSCLC Treatment

Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval ...

July 29, 2024 | News

Sugemalimab Becomes First Anti-PD-L1 mAb Approved in Europe for First-Line Treatment of NSCLC

Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved in Europe for first-line treatment of both squamous and non...

July 29, 2024 | News

Ractigen Therapeutics' RAG-18 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, announced that the U.S. Food and Drug Administration (FDA) has ...

July 26, 2024 | News

Eisai and EcoNaviSta Join Forces to Develop Dementia Ecosystem in Japan’s Super-Aging Society

Eisai Co., Ltd. and EcoNaviSta Inc. announced that they have entered into a business alliance agreement and commenced collaboration with the aim of buildin...

July 25, 2024 | News

Dermaliq Therapeutics Announces Promising Phase 1b/2a Trial Results for DLQ01 in Treating Male Pattern Baldness

Dermaliq Therapeutics, Inc. (Dermaliq), a private, clinical stage dermatology and medical aesthetics company, announced statistically significan...

July 18, 2024 | News

Biosyngen's Groundbreaking CAR-T Therapy BRG01 Approved for Phase II Clinical Trial in China

Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation ...

July 17, 2024 | News

Everest Medicines Announces Positive Topline Data from Phase 3 Trial of Etrasimod for Ulcerative Colitis in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

July 16, 2024 | News

Stay Connected